Skip to main content
JATT
NASDAQ Real Estate & Construction

JATT II Sets Dec 2 Vote on Talawar Merger; Target Flags Going Concern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate
Sentiment info
Negative
Importance info
8
Price
$10.296
Mkt Cap
$80.309M
52W Low
$10
52W High
$23.76
52W Position info
3.0% above low
Off High info
57% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

JATT is trading near its 52-week low of $10 (3.0% above the low).

Summary

JATT II's definitive proxy schedules the December 2, 2026 vote on its merger with preclinical biotech Talawar, backed by a $225 million PIPE — while newly disclosing substantial going-concern doubt at Talawar.


Key Events · M&A and Partnerships · JATT

  • December 2 Vote Set for Talawar Merger

    An extraordinary general meeting is scheduled for December 2, 2026, with redemption elections due 5:00 p.m. ET on November 30, 2026; the illustrative redemption price is about $10.19 per Public Share as of November 3, 2026.

  • Talawar Flags Going-Concern Doubt

    Talawar concluded there is substantial doubt about its ability to continue as a going concern for at least twelve months from the June 30, 2026 financials, and its auditor included an explanatory going-concern paragraph; it had $19.3 million of cash and a $23.7 million accumulated deficit.

  • $225M PIPE Backs the Deal

    The PIPE comprises 22,500,000 shares priced at $10.00 for $225 million gross, with a $125 million minimum cash condition; Talawar's equity value is $120 million, paid in 12,534,278 post-closing shares.

  • Net Cash Per Share Below Deal Value

    Proxy math shows net cash per Public Share of about $8.69 with no redemptions and $8.31 at maximum redemptions, versus the $10.00 per-share value ascribed in the merger agreement.


Analysis · JATT · Real Estate & Construction

The definitive proxy finally puts a date on the long-announced JATT II/Talawar de-SPAC: shareholders vote December 2, 2026, with redemption requests due November 30. What's materially new is that Talawar — a preclinical biotech with no revenue — has concluded there is substantial doubt about its ability to continue as a going concern for at least twelve months from its June 30, 2026 financials, and its auditor added an explanatory going-concern paragraph. The deal leans on a $225 million PIPE at $10.00 per share and a $125 million minimum cash condition; if enough public holders redeem, the proxy's own math shows net cash per share falling to roughly $8.31-$8.69, below the $10.00 deal value. Holders must decide between redeeming near $10.19 and owning a cash-burning, pre-clinical antibody company after closing.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JATT was trading at $10.30 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $80.3M. The 52-week trading range was $10.00 to $23.76. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JATT - Latest Insights

JATT
Aug 25, 2026, 7:03 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.46
Real-time Price: $10.30 info
Change: -$2.16 (-17%) info
Market Cap: $80.309M info
JATT
Aug 12, 2026, 7:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $12.85
Real-time Price: $10.30 info
Change: -$2.55 (-20%) info
Market Cap: $80.309M info
JATT
Jun 29, 2026, 4:00 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $11.63
Real-time Price: $10.30 info
Change: -$1.34 (-11%) info
Market Cap: $80.309M info
JATT
Jun 29, 2026, 3:56 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $11.72
Real-time Price: $10.30 info
Change: -$1.42 (-12%) info
Market Cap: $80.309M info
JATT
Jun 29, 2026, 11:53 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $11.38
Real-time Price: $10.30 info
Change: -$1.08 (-9%) info
Market Cap: $80.309M info